Total Returns (Price + Dividend) 
COPT Defense Properties for the last several years.
Risk Adjusted Returns v/s 
News
Is COPT Defense Properties overvalued or undervalued?
As of 31 October 2025, the valuation grade for COPT Defense Properties moved from expensive to fair, indicating a more favorable assessment of its market position. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 45, a Price to Book Value of 4.25, and an EV to EBITDA of 16.98. In comparison, peers such as Cousins Properties, Inc. have a significantly higher P/E of 82.34, while Sabra Health Care REIT, Inc. is more attractively valued with a P/E of 24.62. Despite the fair valuation, COPT Defense Properties has underperformed against the S&P 500 over the longer term, with a 1Y return of -10.58% compared to the index's 19.89%. However, it has shown resilience over a 3Y period with a return of 9.88%, suggesting potential for recovery. Overall, the company is fairly valued, but its recent performance raises some caution for investors....
Read MoreIs COPT Defense Properties overvalued or undervalued?
As of 31 October 2025, the valuation grade for COPT Defense Properties moved from expensive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 45, a Price to Book Value of 4.25, and an EV to EBITDA of 16.98. In comparison to peers, Cousins Properties has a higher P/E of 82.34, while Sabra Health Care REIT has a more attractive EV to EBITDA of 9.70, indicating that COPT Defense Properties is positioned reasonably within its industry. Despite its fair valuation, COPT Defense Properties has underperformed against the S&P 500 over multiple time frames, with a year-to-date return of -8.40% compared to the S&P 500's 16.30%. This trend continues in the one-year return, where the company declined by 11.27% against the S&P 500's gain of 19.89%....
Read MoreIs COPT Defense Properties overvalued or undervalued?
As of 31 October 2025, the valuation grade for COPT Defense Properties moved from expensive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 45, a Price to Book Value of 4.25, and an EV to EBITDA of 16.98. In comparison, Cousins Properties, Inc. has a higher P/E of 82.34, while Sabra Health Care REIT, Inc. shows a more attractive EV to EBITDA of 9.70, indicating that COPT is positioned reasonably within its peer group. Despite the fair valuation, the company has underperformed relative to the S&P 500, with a year-to-date return of -8.98% compared to the index's 16.30%. This trend continues in the one-year return, where COPT's -12.52% lags behind the S&P 500's 19.89%, suggesting that while the valuation is fair, the stock may face challenges in the near term....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 92 Schemes (52.63%)
Held by 152 Foreign Institutions (16.26%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 1.06% vs 2.45% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 11.05% vs -0.82% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 9.97% vs -7.31% in Dec 2023
YoY Growth in year ended Dec 2024 is 293.67% vs -141.79% in Dec 2023






